BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 15706084)

  • 1. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?
    Tell G; Damante G; Caldwell D; Kelley MR
    Antioxid Redox Signal; 2005; 7(3-4):367-84. PubMed ID: 15706084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The many functions of APE1/Ref-1: not only a DNA repair enzyme.
    Tell G; Quadrifoglio F; Tiribelli C; Kelley MR
    Antioxid Redox Signal; 2009 Mar; 11(3):601-20. PubMed ID: 18976116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target.
    Fishel ML; Kelley MR
    Mol Aspects Med; 2007; 28(3-4):375-95. PubMed ID: 17560642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer.
    Kelley MR; Cheng L; Foster R; Tritt R; Jiang J; Broshears J; Koch M
    Clin Cancer Res; 2001 Apr; 7(4):824-30. PubMed ID: 11309329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
    Robertson KA; Bullock HA; Xu Y; Tritt R; Zimmerman E; Ulbright TM; Foster RS; Einhorn LH; Kelley MR
    Cancer Res; 2001 Mar; 61(5):2220-5. PubMed ID: 11280790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory role of extranuclear apurinic/apyrimidinic endonuclease 1/redox effector factor-1 in reactive astrocytes.
    Baek H; Lim CS; Byun HS; Cho HS; Lee YR; Shin YS; Kim HW; Jeon BH; Kim DW; Hong J; Hur GM; Park JB
    Mol Brain; 2016 Dec; 9(1):99. PubMed ID: 27986089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions.
    Thakur S; Sarkar B; Cholia RP; Gautam N; Dhiman M; Mantha AK
    Exp Mol Med; 2014 Jul; 46(7):e106. PubMed ID: 25033834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
    Laev SS; Salakhutdinov NF; Lavrik OI
    Bioorg Med Chem; 2017 May; 25(9):2531-2544. PubMed ID: 28161249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: Impact on APE1/Ref-1's protein-protein interaction.
    Mantha AK; Dhiman M; Taglialatela G; Perez-Polo RJ; Mitra S
    J Neurosci Res; 2012 Jun; 90(6):1230-9. PubMed ID: 22488727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-kappaB activation.
    Wu HH; Cheng YW; Chang JT; Wu TC; Liu WS; Chen CY; Lee H
    Oncogene; 2010 Jul; 29(30):4330-40. PubMed ID: 20498636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
    Zhang Y; Wang J; Xiang D; Wang D; Xin X
    Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human AP endonuclease/redox factor APE1/ref-1 modulates mitochondrial function after oxidative stress by regulating the transcriptional activity of NRF1.
    Li M; Vascotto C; Xu S; Dai N; Qing Y; Zhong Z; Tell G; Wang D
    Free Radic Biol Med; 2012 Jul; 53(2):237-48. PubMed ID: 22580151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APE1/Ref-1: versatility in progress.
    Jeon BH; Irani K
    Antioxid Redox Signal; 2009 Mar; 11(3):571-4. PubMed ID: 18715142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic Regulation of APE1/Ref-1 as a Therapeutic Target Protein.
    Choi S; Joo HK; Jeon BH
    Chonnam Med J; 2016 May; 52(2):75-80. PubMed ID: 27231670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation.
    Avellini C; Orsaria M; Baccarani U; Adani GL; Lorenzin D; Bresadola V; Bresadola F; Beltrami CA
    Transplant Proc; 2010 May; 42(4):1204-8. PubMed ID: 20534262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1.
    Kelley MR; Parsons SH
    Antioxid Redox Signal; 2001 Aug; 3(4):671-83. PubMed ID: 11554453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Going APE over ref-1.
    Evans AR; Limp-Foster M; Kelley MR
    Mutat Res; 2000 Oct; 461(2):83-108. PubMed ID: 11018583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer clinical utility of the apurinic/apyrimidinic endonuclease/redox factor-1 (APE/Ref-1).
    Zhang Y; Wang J
    Chin J Cancer; 2010 Mar; 29(3):333-9. PubMed ID: 20193121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP.
    Pines A; Perrone L; Bivi N; Romanello M; Damante G; Gulisano M; Kelley MR; Quadrifoglio F; Tell G
    Nucleic Acids Res; 2005; 33(14):4379-94. PubMed ID: 16077024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas.
    Puglisi F; Aprile G; Minisini AM; Barbone F; Cataldi P; Tell G; Kelley MR; Damante G; Beltrami CA; Di Loreto C
    Anticancer Res; 2001; 21(6A):4041-9. PubMed ID: 11911289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.